Interferons Research Area: R&D Systems
Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science
Anti-Human IFN-Beta, Clone MMHB-1 (MAb) | PBL Assay Science
GeneCopoeia: IFN alpha signaling pathway
The Overview of Interferon-CUSABIO
Interferons: role in cancer therapy | Immunotherapy
-Role of IFN secretion during HIV-1 infection. The presence of HIV RNA... | Download Scientific Diagram
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
An Atomic Model of the Interferon-β Enhanceosome: Cell
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine
IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Immune response - IFN alpha/beta signaling pathway Pathway Map - PrimePCR | Life Science | Bio-Rad
Frontiers | The Role of Interferons in Inflammation and Inflammasome Activation
Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
Frontiers | Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases | PLOS ONE
Anti-hIFN beta monoclonal antibody | InvivoGen
The Overview of Interferon-CUSABIO
Relevance of placental type I interferon beta regulation for pregnancy success | Cellular & Molecular Immunology
Interferon type I - Wikipedia
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways: Cell
